Clinical Research Directory
Browse clinical research sites, groups, and studies.
REVIVE Prospective Registry Cohort Study
Sponsor: Peter Belafsky, MD
Summary
The main purpose of this registry is to collect observational, long-term safety and effectiveness data in participants who have received iltamiocel as part of the blinded portion of the REVIVE clinical study.
Official title: Prospective Observational Long-Term Safety and Effectiveness Registry of Patients Who Have Received Iltamiocel as Part of REVIVE Clinical Study in Patients With Tongue Dysphagia Resulting From the Treatment of Head and Neck Cancer
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
31
Start Date
2026-04-30
Completion Date
2032-06-30
Last Updated
2026-04-09
Healthy Volunteers
No
Conditions
Interventions
Other: No Intervention (subjects were previously treated with Iltamiocel). This is a observational study and all participants will be observed with no intervention.
Participants are followed observationally to collect long-term safety and effectiveness data after prior receipt of iltamiocel in the separate Revive clinical trial; no intervention is administered as part of this registry. Long-term safety outcomes and efficacy will be separated in analysis \& reporting
Locations (2)
UC Davis Medical Center
Sacramento, California, United States
UC SanFrancisco Medical Center
San Francisco, California, United States